VenatoRx initiates enrollment in phase 3 trial of cefepime/VNRX-5133 in cUTIs

VenatoRx initiates enrollment in phase 3 trial of cefepime/VNRX-5133 in cUTIs

Submitted by admin on August 30, 2019 - 1:05pm
Source: 
Pharmaceutical Business Review
News Tags: 
VenatoRx
clinical trials
UTIs
complicated urinary tract infections
cefepime
VNRX-5133
Headline: 
VenatoRx initiates enrollment in phase 3 trial of cefepime/VNRX-5133 in cUTIs
snippet: 


VenatoRx Pharmaceuticals today announced that it has initiated enrollment in its Phase 3 trial of cefepime/VNRX-5133 in patients with complicated urinary tract infections (cUTIs)

Do Not Allow Advertisers to Use My Personal information